IP Library Granted Patent US 7,858,358
Granted Patent B2
US 7,858,358 · App. 11/677,927 · Granted Dec 28, 2010

Rapid growing microorganisms for biotechnology applications

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,858,358
App. No.
11/677,927
Granted
Dec 28, 2010
Kind
B2
Abstract

The present invention provides novel rapidly growing microorganisms and methods for their use in cloning or subcloning nucleic acid molecules. The rapid growing microorganisms of the present invention form colonies more rapidly than microorganisms typically used in molecular biology and thus provide a significant improvement in in vitro cloning methods used extensively in molecular biology. The invention also relates to kits and compositions used in the methods of the invention.

Claims (17)

1. A method of transformation comprising:

(a) transforming competent E. coli with at least one vector;

(b) incubating transformed E. coli containing said at least one vector on an appropriate growth medium; and

(c) observing visible colonies comprising said transformed E. coli 7.8 to 8.5 hours after said transformation and incubation,

wherein the growth characteristics of said competent E. coli are such that the E. coli exhibits visible colonies 7.8 to 8.5 hours after transformation and incubation on LB agar at 37° C.

2. The method according to claim 1 , wherein said E. coli is lacZ − .

3. The method according to claim 2 , wherein said E. coli is lacZΔM15.

4. The method according to claim 1 , wherein said E. coli is recA − .

5. The method according to claim 1 , wherein said E. coli is restriction negative.

6. The method according to claim 1 , wherein said E. coli is modification negative.

7. The method according to claim 1 , wherein said E. coli is restriction negative and modification negative.

8. The method according to claim 1 , wherein said E. coli is methylase deficient.

9. The method according to claim 8 , wherein said E. coli is mcrA − .

10. The method according to claim 8 , wherein said E. coli is mcrB − .

11. The method according to claim 1 , wherein said E. coli is endonuclease deficient.

12. The method according to claim 11 , wherein said E. coli is endA1.

13. The method according to claim 1 , wherein the E. coli is suitable for alpha-complementation and selection by blue/white screening.

Assignments (4)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
CHANGE OF NAME Recorded Jan 26, 2010
From: LIFE TECHNOLOGIES, INC.
To: INVITROGEN CORPORATION
Reel/Frame 023851/0392 →
CHANGE OF NAME Recorded Jan 26, 2010
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 023851/0441 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →